Table of Content

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL SKIN CANCER DIAGNOSTICS INDUSTRY
2.1 Summary about Skin Cancer Diagnostics Industry
2.2 Skin Cancer Diagnostics Market Trends
2.2.1 Skin Cancer Diagnostics Production & Consumption Trends
2.2.2 Skin Cancer Diagnostics Demand Structure Trends
2.3 Skin Cancer Diagnostics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Basal Cell Carcinoma
4.2.2 Squamous Cell Carcinoma
4.2.3 Malignant Melanoma
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital
4.3.2 Clinic
4.3.3 Laboratory
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Basal Cell Carcinoma
5.2.2 Squamous Cell Carcinoma
5.2.3 Malignant Melanoma
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital
5.3.2 Clinic
5.3.3 Laboratory
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Basal Cell Carcinoma
6.2.2 Squamous Cell Carcinoma
6.2.3 Malignant Melanoma
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital
6.3.2 Clinic
6.3.3 Laboratory
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Basal Cell Carcinoma
7.2.2 Squamous Cell Carcinoma
7.2.3 Malignant Melanoma
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital
7.3.2 Clinic
7.3.3 Laboratory
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Basal Cell Carcinoma
8.2.2 Squamous Cell Carcinoma
8.2.3 Malignant Melanoma
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Laboratory
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Basal Cell Carcinoma
9.2.2 Squamous Cell Carcinoma
9.2.3 Malignant Melanoma
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital
9.3.2 Clinic
9.3.3 Laboratory
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Alma Lasers
10.1.2 Agilent Technologies Inc
10.1.3 Biolitec Ag
10.1.4 Bruker Corp
10.1.5 Ellipse A/S
10.1.6 GE Healthcare
10.1.7 Leica Microsystems
10.1.8 Michelson Diagnostics
10.1.9 Syneron Medical
10.1.10 Toshiba Medical Systems
10.2 Skin Cancer Diagnostics Sales Date of Major Players (2017-2020e)
10.2.1 Alma Lasers
10.2.2 Agilent Technologies Inc
10.2.3 Biolitec Ag
10.2.4 Bruker Corp
10.2.5 Ellipse A/S
10.2.6 GE Healthcare
10.2.7 Leica Microsystems
10.2.8 Michelson Diagnostics
10.2.9 Syneron Medical
10.2.10 Toshiba Medical Systems
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT

List of Figure

List of Table
Table Skin Cancer Diagnostics Product Type Overview
Table Skin Cancer Diagnostics Product Type Market Share List
Table Skin Cancer Diagnostics Product Type of Major Players
Table Brief Introduction of Alma Lasers
Table Brief Introduction of Agilent Technologies Inc
Table Brief Introduction of Biolitec Ag
Table Brief Introduction of Bruker Corp
Table Brief Introduction of Ellipse A/S
Table Brief Introduction of GE Healthcare
Table Brief Introduction of Leica Microsystems
Table Brief Introduction of Michelson Diagnostics
Table Brief Introduction of Syneron Medical
Table Brief Introduction of Toshiba Medical Systems
Table Products & Services of Alma Lasers
Table Products & Services of Agilent Technologies Inc
Table Products & Services of Biolitec Ag
Table Products & Services of Bruker Corp
Table Products & Services of Ellipse A/S
Table Products & Services of GE Healthcare
Table Products & Services of Leica Microsystems
Table Products & Services of Michelson Diagnostics
Table Products & Services of Syneron Medical
Table Products & Services of Toshiba Medical Systems
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Skin Cancer Diagnostics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Skin Cancer Diagnostics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Skin Cancer Diagnostics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Skin Cancer Diagnostics Market Forecast (Million USD) Share by Demand 2021f-2026f